1, China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) : the anti infection business is expected to achieve double-digit growth in 2022
China Resources Sanjiu Medical & Pharmaceutical Co.Ltd(000999) (000999) disclosed the announcement on the record of investor relations activities. The company’s anti infection business was greatly affected by the policy in the past few years, and the impact of anti infection business has basically dropped to the bottom last year. At the same time, the anti infection business has also developed CMO business in the past few years to help the anti infection business remain stable. In 2022, the anti infection business is expected to achieve double-digit growth driven by the basic adjustment of product structure and new products.
2, Hainan Poly Pharm.Co.Ltd(300630) : it is proposed to repurchase shares between 5 million yuan and 10 million yuan
Hainan Poly Pharm.Co.Ltd(300630) (300630) announced that it plans to repurchase shares with 5-10 million yuan, and the repurchase price shall not exceed 76.76 yuan / share; Esomeprazole sodium for injection of the company passed the technical review of the Dutch drug evaluation committee (CBG).
3, Shenzhen Kexin Communication Technologies Co.Ltd(300565) : sign an order of 68.58 million yuan for network energy products
Shenzhen Kexin Communication Technologies Co.Ltd(300565) (300565) announced that the Finnish subsidiary signed an order for network energy products with international a customers, with an order amount of US $10.78 million (excluding tax), about 68.5791 million yuan. Customer a is one of the world’s leading providers of information and communication technology (ICT) services.
4, Wuxi Apptec Co.Ltd(603259) : the company found no other media reports or market rumors that need clarification or response
Wuxi Apptec Co.Ltd(603259) (603259) issued a change announcement. Neither the company nor its subsidiaries were listed in the “unverified list” by the U.S. Department of Commerce. See the previous Clarification Announcement for details. According to the company’s self-examination, as of the disclosure date of this announcement, the company has not found any other media reports or market rumors that need to be clarified or responded.
5, Anhui Wanwei Updated High-Tech Material Industry Co.Ltd(600063) : it is proposed to acquire 100% equity of wanwei Wansheng with 795 million yuan
Anhui Wanwei Updated High-Tech Material Industry Co.Ltd(600063) (600063) announced that the company plans to purchase 100% equity of wanwei Wansheng held by the counterparty by issuing shares, and plans to issue shares to wanwei group to raise supporting funds. Through friendly negotiation between all parties to the transaction, the price of the subject matter of the transaction is 795 million yuan, and the issue price of the shares issued to purchase assets is 4.32 yuan / share. The amount to be raised this time is no more than 199 million yuan, and the issue price is 4.52 yuan / share. After acquiring wanwei Wansheng, the company realized the vertical extension of PVB resin raw materials to the downstream product line, and became a national leading enterprise covering the whole industrial chain of pva-pvb resin PVB intermediate membrane.
6, Shenzhen Yhlo Biotech Co.Ltd(688575) : New Coronavirus antigen test kit was obtained from Japan PMDA certification, designated to supply
Shenzhen Yhlo Biotech Co.Ltd(688575) (688575) announcement, the New Coronavirus antigen detection kit of the Japanese Medical Research Institute of the Japanese partner Co., Ltd. (MBL) has obtained the license for production and sale of external diagnostic products issued by Japan PMDA in February 10th (the current PMDA certification). The company is designated manufacturer of MBL New Coronavirus antigen detection kit. After obtaining the PMDA certification, the product will be sold in Japan, and can be used for medical testing and home self testing.
7, Semiconductor Manufacturing International Corporation(688981) : capital expenditure is expected to be about $5 billion in 2022
Semiconductor Manufacturing International Corporation(688981) (688981) said that on the premise of relatively stable external environment, the company expects that the growth rate of annual sales revenue in 2022 will be better than the average value of agency industry, and the gross profit margin is higher than the level of the company in 2021. In order to continuously promote the expansion of existing old plants and three new plant projects, this year is still the peak of investment, the capital expenditure is expected to be about US $5 billion, and the capacity increment is expected to be higher than last year. Note: Semiconductor Manufacturing International Corporation(688981) capital expenditure in 2021 is about $4.5 billion.
The fourth quarter revenue of Semiconductor Manufacturing International Corporation(688981) was US $1.58 billion, with a year-on-year increase of 61%. The annual sales revenue of Semiconductor Manufacturing International Corporation(688981) was US $5.44 billion in 2021 and US $3.907 billion in 2020.
The monthly production capacity of Semiconductor Manufacturing International Corporation(688981) increased from 593875 8-inch equivalent wafers in the third quarter of 2021 to 621000 8-inch equivalent wafers in the fourth quarter of 2021.
8, Shanghai Medicilon Inc(688202) : it is proposed to raise no more than 2.16 billion yuan for projects such as pharmaceutical R & D innovation Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) base
According to the announcement of Shanghai Medicilon Inc(688202) (688202), it is proposed to raise no more than 2.16 billion yuan for the Shanghai Medicilon Inc(688202) North Shanghai biomedical R & D innovation Shenzhen New Industries Biomedical Engineering Co.Ltd(300832) base project, the laboratory expansion project of drug discovery and pharmaceutical research and application platform and supplement working capital.
9, Zhejiang Crystal-Optech Co.Ltd(002273) : it is proposed to repurchase shares with RMB 100 million to RMB 200 million
Zhejiang Crystal-Optech Co.Ltd(002273) (002273) announced that it plans to repurchase shares with 100 million yuan to 200 million yuan, and the repurchase price shall not exceed 15.5 yuan / share. On the same day, it was announced that due to production needs, the company plans to purchase coating equipment from the company’s joint-stock company Co., Ltd. (hereinafter referred to as “Japan Guangchi”), with a total transaction amount of about 808 million yen (about 44.462 million yuan at the exchange rate on February 10, 2022), accounting for 0.79% of the company’s audited net assets in 2020.
10, Shenzhen Kingsino Technology Co.Ltd(002548) : the sales revenue of pigs in January decreased by 64.44% year-on-year
Shenzhen Kingsino Technology Co.Ltd(002548) (002548) announced that in January, the sales volume of pigs totaled 70600, the sales revenue totaled 98.2846 million yuan, and the average sales price of pigs was 13.91 yuan / kg (excluding the influence of piglets and breeding pigs, the average price of commercial pigs was 13.67 yuan / kg). The month on month changes of pig sales, sales revenue and average sales price were – 65.75%, – 61.33% and – 20.31% respectively, with year-on-year changes of – 26.70%, – 64.44% and – 69.77% respectively.
